Schuler Jack W's Form 4 filing
Accelerate Diagnostics, Inc (AXDX) · filed Jul 16, 2021
- Accession no.
- 0001628280-21-013967
- Filed
- Jul 16, 2021
- Trade date
- Nov 13, 2019-May 14, 2020
- Filing delay
- 611 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $272.1K. It was filed 611 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Jack WCIK 0001021412 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2019 | Common Stock | JOtherAcquired | +5,000 | $16.04 | +$80,200 | 1,267,023 | Indirect | |
| May 14, 2020 | Common Stock | PPurchaseAcquired | +29,577 | $9.20F2 | +$272,108.4 | 16,633,101 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.97 to $9.40, inclusive. The reporting person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
Referenced by the price of 1 transaction in Table I.